LongView Wealth Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-10,500
Closed -$997K 238
2026
Q1
$997K Hold
10,500
0.25% 90
2025
Q4
$963K Hold
10,500
0.23% 89
2025
Q3
$601K Hold
10,500
0.16% 110
2025
Q2
$620K Sell
10,500
-3,500
-25% -$226K 0.19% 100
2025
Q1
$1.02M Hold
14,000
0.31% 70
2024
Q4
$1.16M Hold
14,000
0.35% 64
2024
Q3
$1M Sell
14,000
-1,400
-9% -$98.8K 0.32% 66
2024
Q2
$1.05M Hold
15,400
0.39% 58
2024
Q1
$826K Sell
15,400
-2,765
-15% -$149K 0.33% 64
2023
Q4
$978K Buy
+18,165
New +$885K 0.44% 52

Other funds holding GMED

LongView Wealth Management's GMED Position: Q2 2026 in Review

LongView Wealth Management sold out of Globus Medical (GMED) in Q2 2026, closing a stake of 10,500 shares — an estimated $997K sold.

LongView Wealth Management first reported a position in GMED in Q4 2023 and held it in 10 quarters. The position peaked at $1.16M in Q4 2024. 597 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • LongView Wealth Management reported no remaining Globus Medical position as of Q2 2026 after selling out during the quarter.
  • LongView Wealth Management sold 10,500 Globus Medical shares in Q2 2026, an estimated $997K.
  • LongView Wealth Management first reported a position in Globus Medical in Q4 2023 and held it in 10 quarters.
  • LongView Wealth Management's Globus Medical position peaked at $1.16M in Q4 2024.
  • 597 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on LongView Wealth Management's 13F filing for Q2 2026, filed 17 Jul 2026.